Table: begin end state 1 11 non-cytoplasmic 12 32 transmembrane 33 44 cytoplasmic 45 64 transmembrane 65 87 non-cytoplasmic 88 112 transmembrane 113 123 cytoplasmic 124 142 transmembrane 143 161 non-cytoplasmic 162 181 transmembrane 182 250 cytoplasmic 251 272 transmembrane 273 282 non-cytoplasmic 283 307 transmembrane 308 319 cytoplasmic 320 342 transmembrane 343 357 non-cytoplasmic 358 377 transmembrane 378 382 cytoplasmic 383 401 transmembrane 402 406 non-cytoplasmic 407 432 transmembrane 433 444 cytoplasmic 445 468 transmembrane 469 470 non-cytoplasmic
Input: >Pf1N1B4_5074 LLFLVLKYKFQPFVALMLVSILVALVAGVKPADLVATIEGGMGKTLGHIAIIIALGAMIG RIIELSGGAEALAKTLITRFGNRRTPLALTIAGFMVGVPVFFEVGVIILMPLAYGVARSA RKPLLVFALPMCAALLTVHAFLPPHPGAVAAASQLGADLGRVLMFGLPITAFLCYVGYRV AGRMTRRVYPMTDDIRAEVYGPHVTNEDLAAWSNGNDKSPERAAVAASHMGLEEATSSIV SKLPPAPPPGFGLIVSLIVLPIILILLGTLSTSLLPADSVLRGIMTVLGAPLVALLIDTL LCAWLLGSRRGWSRTQVSDVIGSALPGVAMVILIAGAGGVFGKVLVDTGIGAVVSDMLRT TGLPVLALGFLLTMLLRAVQGSTTVALVTTAGIISPLIVTLDLTANHMALLCLAMGGGGL AMSHINDAGYWIFTKLSGLNVADGLRTWTVLTTLLGTLGFGITLLIWPFV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server